Biologic TNF inhibiting agents for treatment of rheumatoid arthritis: persistence and dosing patterns in Germany

OBJECTIVE: To obtain detailed real-world data on persistence and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in rheumatoid arthritis (RA) patients treated in Germany. METHODS: In this retrospective observational study claims data of a major German...

Descripción completa

Detalles Bibliográficos
Autores principales: Neubauer, Sarah, Cifaldi, Mary, Mittendorf, Thomas, Ganguli, Arijit, Wolff, Malte, Zeidler, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502064/
https://www.ncbi.nlm.nih.gov/pubmed/26208932
http://dx.doi.org/10.1186/s13561-014-0032-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502064/
https://www.ncbi.nlm.nih.gov/pubmed/26208932
http://dx.doi.org/10.1186/s13561-014-0032-4

Ejemplares similares